Publications in journals with an impact factor higher than 5
Teixeira J, Basit F, Willems PHGM, Wagenaars JA, van de Westerlo E, Amorim R, Cagide F, Benfeito S, Oliveira C, Borges F, Oliveira PJ, Koopman WJH. Free Radic Biol Med. 2020 Dec 22:S0891-5849(20)31686-5. doi: 10.1016/j.freeradbiomed.2020.12.023.
IF=6.170
Joining European Scientific Forces to Face Pandemics.
Vasconcelos MH, Alcaro S, Arechavala-Gomeza V, Baumbach J, Borges F, Brevini TAL, Rivas JL, Devaux Y, Hozak P, Keinänen-Toivola MM, Lattanzi G, Mohr T, Murovska M, Prusty BK, Quinlan RA, Pérez-Sala D, Scheibenbogen C, Schmidt HHHW, Silveira I, Tieri P, Tolios A, Riganti C. Trends Microbiol. 2020 Nov 6:S0966-842X(20)30270-5. doi: 10.1016/j.tim.2020.10.008. Online ahead of print.
IF=13.546
Silva TB, Borges F, Serrão MP, Soares-da-Silva P. Drug Discov Today. 2020 Jul 17:S1359-6446(20)30295-6. doi: 10.1016/j.drudis.2020.07.015. Online
IF=6.369
Looking for new xanthine oxidase inhibitors: 3-Phenylcoumarins versus 2-phenylbenzofurans.
Era B, Delogu GL, Pintus F, Fais A, Gatto G, Uriarte E, Borges F, Kumar A, Matos MJ. Int J Biol Macromol. 2020 Nov 1;162:774-780. doi: 10.1016/j.ijbiomac.2020.06.152. Epub 2020 Jun 20.
IF=5.162
Structure-Based Optimization of Coumarin hA3 Adenosine Receptor Antagonists.
Matos MJ, Vilar S, Vazquez-Rodriguez S, Kachler S, Klotz KN, Buccioni M, Delogu G, Santana L, Uriarte E, Borges F. J Med Chem. 2020 Mar 12;63(5):2577-2587. doi: 10.1021/acs.jmedchem.9b01572. Epub 2019 Dec 4.
IF=6.205
Chavarria D, Fernandes C, Silva V, Silva C, Gil-Martins E, Soares P, Silva T, Silva R, Remião F, Oliveira PJ, Borges F. Eur J Med Chem. 2020 Jan 1;185:111770. doi: 10.1016/j.ejmech.2019.111770. Epub 2019 Oct 16.
IF=5.572
Comments